Oncology News

A cohort study published in JAMA Oncology found substantial state variations in racial and ethnic disparities in triple-negative breast cancer incidence, with Black women in four states having the highest rates.

Women using hormone therapy for menopause symptoms did not have a greater risk for lung cancer than their untreated peers, and may have had lower risk with higher HT dosage and duration, according to study data published in Menopause.

Women who had surgery up to 8 weeks after breast cancer diagnosis did not have worse overall survival than those with earlier times to surgery, according to a case series with more than 373,000 women published in JAMA Surgery.

Daily or near daily aspirin use reduced the risk for nonmucinous ovarian cancer across most strata of genetic risk based on a polygenic score, according to a case-control study published in JAMA Network Open.

Omission of whole-breast irradiation did not appear to have a negative impact on survival or risk for distant metastases among older women with early-stage hormone receptor-positive breast cancer, according to phase 3 study results.

Clinicians should advocate for opportunistic salpingectomy among patients undergoing surgery for benign pelvic diseases to prevent ovarian cancer, according to a consensus statement from the Ovarian Cancer Research Alliance.

The FDA granted regular approval to dostarlimab-gxly for treatment of certain women with endometrial cancer.

Longer duration of ovulation across the life span was associated with a greater risk for epithelial ovarian cancer, according to data published in the Journal of the National Cancer Institute.

Up to 8 months before diagnosis, women with ovarian cancer purchased more over-the-counter pain and indigestion medications vs. women without ovarian cancer, according to findings of an observational case-control study.

Presence of certain bacteria in the microbiome may indicate early-stage ovarian cancer, according to data published in Scientific Reports.